We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01354093
Recruitment Status : Completed
First Posted : May 16, 2011
Last Update Posted : June 23, 2017
Information provided by (Responsible Party):
Paul S. Bernstein, University of Utah

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2017
  Study Completion Date : January 2017